Ketamine Nasal spray - Search News

US FDA approves new nasal spray for depression treatment

Hosted on MSN · 7h

FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as standalone treatment

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult population.

Ketamine Nasal Spray Approved as Standalone Treatment for Tough Depression Cases

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other options.

Fox Business · 1d

J&J's ketamine-derived nasal spray approved by FDA to treat depression

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those who had an inadequate response to oral antidepressants.

J&J’s ketamine-based drug approved as standalone treatment

"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...

Inquirer on MSN2d

Controlled drug Ketamine a lifeline for patients with severe depression in S’pore

Ketamine therapy is now a mainstream prescription for treatment-resistant depression. Read more at straitstimes.com.

10h

If You Pre-Order The Galaxy S25 Ultra, Here’s How to Save 80% Via The Samsung’s Site

Get your itchy fingers ready — Samsung’s Galaxy Unpacked event is today at 1pm Eastern, which means the long-awaited ...

16h

The 3 worst drinks that increase Alzheimer’s risk — including one health-conscious people like

California gastroenterologist Dr. Saurabh Sethi has called out three popular drinks that increase the risk of Alzheimer’s.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results